Analyst - Business intelligence Developer at Eli Lilly and Company

Cork, County Cork, Ireland

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, FinanceIndustries

Requirements

  • Degree in sciences or quantitative discipline (e.g., Statistics, Mathematics, Finance, Engineering, or Computer Sciences) from Tier-I institute; MBA/post-graduation preferred
  • 3+ years’ experience in data modelling and schema design, preferably within Microsoft Fabric or similar platforms
  • 3+ years' experience in developing, deploying, and maintaining analytical models in production environments, including performance monitoring and model lifecycle management
  • 3+ years' experience in data visualization in Power BI
  • Skilled in leveraging DAX in Power BI, ensuring scalable and responsive Power BI reports across large datasets
  • Strong understanding of financial data structures and reporting requirements
  • Familiarity with SAP S4, Ariba, and other finance-related data sources is a plus
  • Strong work ethic and personal motivation (behavioral skills)

Responsibilities

  • Design and implement data models using modern data platforms (e.g., Microsoft Fabric, Databricks, Snowflake), ensuring alignment with enterprise architecture and analytics goals
  • Deploy and operationalise analytical models, ensuring they are scalable, maintainable, and integrated into business workflows
  • Work closely with finance teams, data engineers, and business analysts to understand requirements and deliver data solutions that meet operational and strategic needs
  • Design and implement intuitive Power BI reports and enhance with advanced analytics
  • Build and maintain datasets that integrate SAP and non-SAP financial data sources, enabling seamless access for reporting and analytics
  • Ensure metadata is accurately captured and maintained for lineage and governance
  • Adhere to enterprise data standards and governance frameworks
  • Assess the functions objectives and requirements of the organisation partnering with us
  • Determine the appropriate method of data integration and methodology, analyse and interpret information gained, and implement recommendations
  • Use data to identify problems concerned with business strategy, organisation, procedures & performance and present findings
  • Analyse and interpret information gained and make recommendations to business partners

Skills

Microsoft Fabric
Databricks
Snowflake
Data Modelling
Schema Design
Data Visualisation
Analytics
SQL
Python
Power BI

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI